Holzer & Holzer, LLC announced an investigation into whether Hims & Hers Health, Inc. complied with federal securities laws. The investigation follows a Federal Trade Commission lawsuit filed on July 29, 2026, alleging the company fails to clearly disclose that it charges consumers for prescriptions almost immediately after they submit an intake form, despite telling consumers they will be able to consult with a medical provider to find a treatment that is right for them. Following this news, the price of the company’s stock dropped. The law firm is encouraging investors who purchased Hims & Hers stock and suffered a loss to contact Corey Holzer or Joshua Karr to discuss their legal rights.
Hims Hers Health IncFTC lawsuit alleges failure to disclose prescription charges, causing stock drop.